CorMedix (CRMD)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.33 (+3.20%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of CorMedix (CRMD)
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Key Insights

Critical company metrics and information

  • Share Price

    $10.32

  • Market Cap

    $626.19 Million

  • Total Outstanding Shares

    60.68 Million Shares

  • Total Employees

    82

  • Dividend

    No dividend

  • IPO Date

    May 13, 2010

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Phone Number

    908-517-9500

  • Address

    300 connell drive, Berkeley heights, NJ, 07922

  • Homepage

    https://www.cormedix.com

Historical Stock Splits

If you bought 1 share of CRMD before March 26, 2019, you'd have 0.20 shares today.
Execution DateSplit Amount
March 26, 20191-for-5 (Reverse Split)

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$-18.11 Million
Net Cash Flow From Operating Activities, Continuing$-55.75 Million
Net Cash Flow From Financing Activities$15.50 Million
Net Cash Flow From Investing Activities$22.13 Million
Exchange Gains/Losses$1,945.00
Net Cash Flow From Investing Activities, Continuing$22.13 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Income/Loss Attributable To Parent$-46.15 Million
Preferred Stock Dividends And Other Adjustments$0.00
Basic Earnings Per Share$-0.81
Basic Average Shares$118.57 Million
Operating Expenses$61.21 Million
Diluted Average Shares$118.57 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Current Liabilities$18.48 Million
Noncurrent Assets$4.43 Million
Equity Attributable To Noncontrolling Interest$0.00
Accounts Payable$1.34 Million
Liabilities And Equity$77.59 Million
Inventory$6.65 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2025 Financhle. All Rights Reserved.